Dyskinesia is a type of involuntary movement seen in Parkinson’s disease that is often caused by levodopa, a type of ...

Disease progression in people with Parkinson's disease can be accurately monitored using sensors, removing some of the ...

The compound, SB-0110, was tested in rodent and non-human primate models of Parkinson’s disease during preclinical tests.

A technique that uses videos and machine learning to quantify motor symptoms in early-stage Parkinson's disease could help reveal signs of the disease and other movement disorders earlier, which could ...

Symptoms of Parkinson’s disease can affect your daily life and well-being. Gocovri (amantadine) is a medicine used to manage uncontrolled movements in people taking a medicine called levodopa for ...

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson's disease treatments. Published in Nature ...

Share on Pinterest Athletes who develop chronic traumatic encephalopathy (CTE) from playing contact sports may have a high risk of developing Parkinsonism. Alexey Kuzma/Stocksy Playing contact sports ...

Two Cadillac residents share how Parkinson’s disease changed their lives and how a local support group has helped them ...

Parkinson's disease usually begins after the age of 60 years, although about 5–10 per cent of patients develop symptoms ...

Tardive dyskinesia (TD) is an involuntary movement disorder caused by long-term dopamine-blocking medications. Prolonged use may create chemical imbalances in brain areas controlling movement.

Disease progression in those with Parkinson’s disease can accurately be monitored with the use of sensors, removing some of the limitations of wearable technologies, a new study reports. During this ...